Nkarta, Inc. Weighted Average Number of Shares Issued, Basic
Nkarta, Inc. (NKTX) reported Weighted Average Number of Shares Issued, Basic of 71.49 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesIssuedBasic · last filed 2026-08-10
- Nkarta, Inc. weighted average number of shares issued, basic for the quarter ending 2026-06-30 was 71.49M shares, a 0.73% increase year-over-year.
- Nkarta, Inc. weighted average number of shares issued, basic for the quarter ending 2026-03-31 was 71.26M shares, a 0.48% increase year-over-year.
- Nkarta, Inc. weighted average number of shares issued, basic for the quarter ending 2025-09-30 was 71.02M shares, a 0.65% increase year-over-year.
- Nkarta, Inc. weighted average number of shares issued, basic for the quarter ending 2025-06-30 was 70.98M shares, a 0.69% increase year-over-year.
- Nkarta, Inc. weighted average number of shares issued, basic for fiscal 2025 was 70.99M shares, a 8.27% increase from fiscal 2024.
- Nkarta, Inc. weighted average number of shares issued, basic for fiscal 2024 was 65.57M shares, a 33.78% increase from fiscal 2023.
- Nkarta, Inc. weighted average number of shares issued, basic for fiscal 2023 was 49.01M shares, a 12.33% increase from fiscal 2022.
- Nkarta, Inc. weighted average number of shares issued, basic for fiscal 2022 was 43.64M shares, a 32.63% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Issued, Basic 3 month | Weighted Average Number of Shares Issued, Basic 6 month | Weighted Average Number of Shares Issued, Basic 9 month | Weighted Average Number of Shares Issued, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 71.49M shares 10-Q · filed 2026-08-10 | 71.38M shares 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | 71.26M shares 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 70.99M shares 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 71.02M shares 10-Q · filed 2025-11-10 | 70.97M shares 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | 70.98M shares 10-Q · filed 2026-08-10 | 70.95M shares 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | 70.92M shares 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 65.57M shares 10-K · filed 2026-03-25 | |||
| 2024-09-30 | 70.56M shares 10-Q · filed 2025-11-10 | 63.88M shares 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | 70.49M shares 10-Q · filed 2025-08-12 | 60.51M shares 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | 50.52M shares 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | 49.01M shares 10-K · filed 2025-03-26 | |||
| 2023-09-30 | 49.06M shares 10-Q · filed 2024-11-07 | 48.99M shares 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | 48.97M shares 10-Q · filed 2024-08-13 | 48.95M shares 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | 48.92M shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 43.64M shares 10-K · filed 2024-03-21 | |||
| 2022-09-30 | 48.63M shares 10-Q · filed 2023-11-09 | 41.88M shares 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | 43.84M shares 10-Q · filed 2023-08-10 | 38.45M shares 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | 33.00M shares 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 32.90M shares 10-K · filed 2023-03-16 | |||
| 2021-09-30 | 32.94M shares 10-Q · filed 2022-11-09 | 32.88M shares 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | 32.88M shares 10-Q · filed 2022-08-11 | 32.84M shares 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | 32.81M shares 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 16.92M shares 10-K · filed 2022-03-17 | |||
| 2020-09-30 | 31.10M shares 10-Q · filed 2021-11-10 | 11.62M shares 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | 1.82M shares 10-Q · filed 2021-08-12 | 1.78M shares 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 1.74M shares 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | 1.71M shares 10-K · filed 2021-03-25 | |||
| 2019-09-30 | 1.72M shares 10-Q · filed 2020-11-12 | 1.71M shares 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | 1.70M shares 10-Q · filed 2020-08-20 | 1.70M shares 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |